Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Cancer Microbiota: EMT and Inflammation as Shared Molecular Mechanisms Associated with Plasticity and Progression
Daniele Vergara, Pasquale Simeone, Marina D’Amato, et al.
Journal of Oncology (2019) Vol. 2019, pp. 1-16
Open Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

Gut–Skin Axis: Current Knowledge of the Interrelationship between Microbial Dysbiosis and Skin Conditions
Britta De Pessemier, Lynda Grine, Melanie Debaere, et al.
Microorganisms (2021) Vol. 9, Iss. 2, pp. 353-353
Open Access | Times Cited: 372
A pan-cancer mycobiome analysis reveals fungal involvement in gastrointestinal and lung tumors
Anders B. Dohlman, Jared Klug, Marissa Mesko, et al.
Cell (2022) Vol. 185, Iss. 20, pp. 3807-3822.e12
Open Access | Times Cited: 227
Microbiota medicine: towards clinical revolution
Prisca Gebrayel, Carole Nicco, Souhaila Al Khodor, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 192
The role of the microbiome in ovarian cancer: mechanistic insights into oncobiosis and to bacterial metabolite signaling
Adrienn Sipos, Gyula Ujlaki, Edit Mikó, et al.
Molecular Medicine (2021) Vol. 27, Iss. 1
Open Access | Times Cited: 101
Microbiome in cancer: Role in carcinogenesis and impact in therapeutic strategies
Md. Mominur Rahman, Md. Rezaul Islam, Sheikh Shohag, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 149, pp. 112898-112898
Open Access | Times Cited: 80
Intratumoural microbiota: a new frontier in cancer development and therapy
Yaqi Cao, Hui Xia, Xueyun Tan, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 54
Short-chain fatty acids in cancer pathogenesis
Mark A. Feitelson, Alla Arzumanyan, Arvin Medhat, et al.
Cancer and Metastasis Reviews (2023) Vol. 42, Iss. 3, pp. 677-698
Open Access | Times Cited: 42
Pathways of Gastric Carcinogenesis, Helicobacter pylori Virulence and Interactions with Antioxidant Systems, Vitamin C and Phytochemicals
James Wei Tatt Toh, Robert Wilson
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 17, pp. 6451-6451
Open Access | Times Cited: 108
Indolepropionic Acid, a Metabolite of the Microbiome, Has Cytostatic Properties in Breast Cancer by Activating AHR and PXR Receptors and Inducing Oxidative Stress
Zsanett Sári, Edit Mikó, Tündé Kovàcs, et al.
Cancers (2020) Vol. 12, Iss. 9, pp. 2411-2411
Open Access | Times Cited: 102
Frizzled7 Promotes Epithelial-to-mesenchymal Transition and Stemness Via Activating Canonical Wnt/β-catenin Pathway in Gastric Cancer
Guanman Li, Qiao Su, Haibo Liu, et al.
International Journal of Biological Sciences (2018) Vol. 14, Iss. 3, pp. 280-293
Open Access | Times Cited: 96
The Gut–Vascular Barrier as a New Protagonist in Intestinal and Extraintestinal Diseases
Natalia Di Tommaso, Francesco Santopaolo, Antonio Gasbarrini, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1470-1470
Open Access | Times Cited: 30
Targeting gut barrier dysfunction with phytotherapies: Effective strategy against chronic diseases
Priyankar Dey
Pharmacological Research (2020) Vol. 161, pp. 105135-105135
Closed Access | Times Cited: 54
Oncobiosis and Microbial Metabolite Signaling in Pancreatic Adenocarcinoma
Borbála Kiss, Edit Mikó, Éva Sebő, et al.
Cancers (2020) Vol. 12, Iss. 5, pp. 1068-1068
Open Access | Times Cited: 50
Gut Microbiota: Influence on Carcinogenesis and Modulation Strategies by Drug Delivery Systems to Improve Cancer Therapy
Runqi Zhu, Tianqun Lang, Wenlu Yan, et al.
Advanced Science (2021) Vol. 8, Iss. 10
Open Access | Times Cited: 42
Role of the microbiome in oral cancer occurrence, progression and therapy
Zhengrui Li, Yuan Liu, Ling Zhang
Microbial Pathogenesis (2022) Vol. 169, pp. 105638-105638
Closed Access | Times Cited: 34
Modulating Microbiota as a New Strategy for Breast Cancer Prevention and Treatment
Huixin Wu, Sebanti Ganguly, Trygve O. Tollefsbol
Microorganisms (2022) Vol. 10, Iss. 9, pp. 1727-1727
Open Access | Times Cited: 33
Gut Metabolites and Breast Cancer: The Continuum of Dysbiosis, Breast Cancer Risk, and Potential Breast Cancer Therapy
Kayla Jaye, Dennis Chang, Chun Guang Li, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9490-9490
Open Access | Times Cited: 30
Evaluation of multidrug resistance in the Gram-negative microbiome of cancer patients and the adverse effects of their metabolites on albino rats and epithelial or fibroblasts cell lines
Mervat Morsy Abbas Ahmed El-Gendy, Ahmed Al‐Emam, Khaled G. Abdel-Wahhab, et al.
Infectious Agents and Cancer (2025) Vol. 20, Iss. 1
Open Access
Indoxylsulfate, a Metabolite of the Microbiome, Has Cytostatic Effects in Breast Cancer via Activation of AHR and PXR Receptors and Induction of Oxidative Stress
Zsanett Sári, Edit Mikó, Tündé Kovàcs, et al.
Cancers (2020) Vol. 12, Iss. 10, pp. 2915-2915
Open Access | Times Cited: 45
Chronic Stress: Impacts on Tumor Microenvironment and Implications for Anti-Cancer Treatments
Wentao Tian, Yi Liu, Chenghui Cao, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 39
Microbiome Assisted Tumor Microenvironment: Emerging Target of Breast Cancer
Rama Rao Malla, Rakshmitha Marni, Seema Kumari, et al.
Clinical Breast Cancer (2021) Vol. 22, Iss. 3, pp. 200-211
Closed Access | Times Cited: 38
The Bladder Microbiome Is Associated with Epithelial–Mesenchymal Transition in Muscle Invasive Urothelial Bladder Carcinoma
Wei Tse Li, Anjali Iyangar, Rohan G. Reddy, et al.
Cancers (2021) Vol. 13, Iss. 15, pp. 3649-3649
Open Access | Times Cited: 36
Roles of Microbiota in Cancer: From Tumor Development to Treatment
Zohreh Bagheri, Leila Moeinzadeh, Mahboobeh Razmkhah
Journal of Oncology (2022) Vol. 2022, pp. 1-15
Open Access | Times Cited: 22
Emerging implications of bacterial biofilm in cancer biology: Recent updates and major perspectives
Manish Kushwaha, Vanditha Nukala, Akhilesh Kumar Singh, et al.
Gut Microbes Reports (2024) Vol. 1, Iss. 1, pp. 1-20
Open Access | Times Cited: 4
TAZ Controls Helicobacter pylori-Induced Epithelial–Mesenchymal Transition and Cancer Stem Cell-Like Invasive and Tumorigenic Properties
Camille Tiffon, Julie Giraud, Silvia Molina‐Castro, et al.
Cells (2020) Vol. 9, Iss. 6, pp. 1462-1462
Open Access | Times Cited: 37
Page 1 - Next Page

Scroll to top